Hydrozolin ISDN 20/37.5mg Tablet 10s

Hydrozolin ISDN 20/37.5mg Tablet 10s combines hydralazine and isosorbide dinitrate, two vasodilator medicines that work through complementary mechanisms to improve cardiac function and circulation. The combination is particularly beneficial in patients with chronic heart failure and in those who cannot tolerate certain other heart failure therapies.

Hydralazine is a direct-acting arterial vasodilator that relaxes smooth muscles in the arterial walls, reducing systemic vascular resistance and lowering afterload. By decreasing the resistance against which the heart must pump, hydralazine improves cardiac output and reduces cardiac workload.

Isosorbide dinitrate is an organic nitrate that primarily dilates veins and, to a lesser extent, arteries. It works by releasing nitric oxide, which relaxes vascular smooth muscle and reduces preload by decreasing venous return to the heart. This reduces myocardial oxygen demand and improves symptoms associated with heart failure and angina.

Together, hydralazine and isosorbide dinitrate provide balanced vasodilation by reducing both preload and afterload. This dual action improves cardiac efficiency, enhances oxygen delivery, and reduces symptoms such as breathlessness, fatigue, and exercise intolerance in patients with heart failure.

Hydrozolin ISDN 20/37.5mg Tablet 10s is commonly prescribed in chronic heart failure, particularly in patients with reduced ejection fraction. It may also be used in selected patients with angina or hypertension under medical supervision. Regular monitoring is important to assess blood pressure response, symptom improvement, and potential adverse effects.

The uses of Hydrozolin ISDN 20/37.5mg Tablet 10s are as follows:

Chronic Heart Failure

Hydrozolin ISDN 20/37.5mg Tablet 10s is used to improve symptoms, exercise tolerance, and survival in patients with heart failure with reduced ejection fraction.

Heart Failure in Specific Populations

The combination has demonstrated significant benefit in certain patient populations, particularly when added to standard heart failure therapy.

Angina Pectoris

It may help reduce chest pain by improving blood flow and decreasing myocardial oxygen demand.

Hypertension

Hydralazine contributes to blood pressure reduction through arterial vasodilation in selected patients.

Reduced Cardiac Workload

The combination reduces both preload and afterload, helping the heart pump more efficiently.

Improved Circulation

Vasodilation improves peripheral and coronary blood flow, enhancing tissue oxygen delivery.

Here are the benefits of Hydrozolin ISDN 20/37.5mg Tablet 10s:

• Improves Heart Function: Hydralazine and isosorbide dinitrate together reduce the workload on the heart, helping it pump blood more efficiently.

• Reduces Symptoms of Heart Failure: The combination may help relieve breathlessness, fatigue, and exercise intolerance in patients with chronic heart failure.

• Balanced Vasodilation: Hydralazine reduces arterial resistance while isosorbide dinitrate reduces venous return, providing comprehensive cardiovascular support.

• Enhances Blood Flow: Vasodilation improves circulation to the heart and peripheral tissues, supporting oxygen delivery.

• May Improve Survival in Heart Failure: The combination has shown clinical benefit in selected patients with heart failure when used alongside standard therapy.

Like all medicines, Hydrozolin ISDN 20/37.5mg Tablet 10s may cause side effects in some individuals.

Common Side Effects:

• Headache: Headache is one of the most common side effects, particularly during the early phase of treatment.

• Dizziness: Light-headedness or dizziness may occur due to blood pressure lowering effects.

• Flushing: Warmth or redness of the face may occur because of vasodilation.

Uncommon Side Effects:

• Rapid Heartbeat: Some patients may experience palpitations or reflex tachycardia.

• Nausea: Mild gastrointestinal discomfort or nausea may occur in some individuals.

• Low Blood Pressure: Excessive blood pressure reduction may cause weakness or faintness.

Serious Side Effects (Require Immediate Medical Attention):

• Severe Hypotension: Marked dizziness, fainting, or collapse requires urgent medical attention.

• Severe Allergic Reaction: Swelling of the face, lips, or throat with difficulty breathing requires immediate care.

• Lupus-Like Syndrome: Long-term hydralazine use may rarely cause symptoms such as joint pain, fever, and rash resembling lupus.

Always consult your doctor if side effects persist or worsen.

To ensure safe use:

• Use exactly as prescribed by your doctor.

• Take at the same time each day for consistent therapeutic benefit.

• Swallow the tablets whole with water unless otherwise instructed.

• Do not suddenly stop the medicine without consulting your doctor.

• Monitor blood pressure regularly as advised during treatment.

Hydrozolin ISDN 20/37.5mg Tablet 10s works through complementary vasodilatory mechanisms that improve cardiovascular function and reduce cardiac workload.

Hydralazine acts primarily on arteries, relaxing vascular smooth muscle and reducing systemic vascular resistance. This lowers afterload, meaning the heart pumps against less resistance, thereby improving cardiac output and reducing strain on the heart.

Isosorbide dinitrate primarily dilates veins by releasing nitric oxide, which relaxes vascular smooth muscle. Venous dilation reduces preload by decreasing the amount of blood returning to the heart, thereby lowering myocardial oxygen demand and relieving symptoms associated with heart failure and angina.

Together, hydralazine and isosorbide dinitrate reduce both preload and afterload, improving circulation, enhancing oxygen delivery, and increasing the efficiency of cardiac pumping.

A few practical measures can help improve treatment outcomes and ensure safe use of Hydrozolin ISDN 20/37.5mg Tablet 10s:

• Take exactly as prescribed: Consistent dosing improves heart failure symptom control and cardiovascular benefit.

• Rise slowly from sitting or lying positions: Helps reduce dizziness and fainting caused by blood pressure lowering.

• Avoid sudden discontinuation: Abrupt stopping may worsen symptoms or precipitate angina in susceptible patients.

• Limit alcohol intake: Alcohol may intensify dizziness, headache, and hypotension.

• Monitor blood pressure regularly: Regular monitoring helps detect excessive blood pressure reduction.

• Inform your doctor about persistent headaches: Nitrate-related headaches are common initially but may require management if severe.

Proper storage is important to maintain the stability and effectiveness of Hydrozolin ISDN 20/37.5mg Tablet 10s:

• Store at room temperature: Keep away from heat, moisture, and direct sunlight.

• Keep in original packaging: Protects the medicine from environmental exposure and maintains stability.

• Keep out of reach of children: Store safely to prevent accidental ingestion.

• Check expiry before use: Do not use after the expiry date mentioned on the packaging.

Hydrozolin ISDN 20/37.5mg Tablet 10s may interact with certain foods and beverages:

• Avoid excessive alcohol: Alcohol may significantly increase the risk of dizziness, fainting, and low blood pressure.

• Maintain adequate hydration: Proper hydration may help reduce dizziness associated with vasodilator therapy.

• Take consistently with regard to meals: Follow your doctor's advice on whether to take the medicine with or without food for optimal absorption and tolerability.

Hydrozolin ISDN 20/37.5mg Tablet 10s may interact with the following medicines:

• Phosphodiesterase-5 Inhibitors: Medicines such as sildenafil or tadalafil may cause severe hypotension when combined with nitrates.

• Antihypertensive Medicines: Combined use with blood pressure-lowering medicines may enhance hypotensive effects.

• Alcohol and Sedatives: May worsen dizziness, drowsiness, and fainting risk.

• Other Nitrate Medicines: Concurrent use may increase the risk of severe hypotension and nitrate-related adverse effects.

• Monoamine Oxidase Inhibitors (MAOIs): Combined use may potentiate blood pressure changes and require caution.

Hydrozolin ISDN 20/37.5mg Tablet 10s should be used carefully in the following conditions:

• Hypotension: Vasodilatory effects may worsen low blood pressure and increase fainting risk.

• Coronary Artery Disease: Sudden blood pressure changes may occasionally worsen angina in susceptible individuals.

• Lupus-like Syndrome: Hydralazine has been associated with drug-induced lupus in rare cases, particularly with prolonged use.

• Severe Anaemia: Nitrate therapy may worsen symptoms in patients with significant anaemia.

• Raised Intracranial Pressure: Nitrates may increase intracranial pressure and require caution in affected patients.

Usually taken two to three times daily or as directed by your doctor. The exact dose depends on the severity of heart failure, blood pressure response, and individual patient tolerance.

If a dose is missed, take it as soon as remembered. If it is nearly time for the next dose, skip the missed dose and continue the regular dosing schedule. Do not double the dose to make up for a missed one.